调免消癥汤加减联合常规西医治疗宫颈高危HPV持续感染的临床疗效

doi:10.3969/j.issn.1671-7171.2022.03.016

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1125 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To explore the effect of modified Tiaomianxiaozheng decoction on cervical high risk human papilloma virus (HR-HPV) persistent infection (spleen deficiency and dampness excess syndrome).【Methods】A total of 94 patients with persistent cervical HR-HPV infection (spleen deficiency and dampness syndrome) were randomly divided into 2 groups with 47 cases in each group. The control group received western medicine treatment, and the observation group was treated with Tiaomianxiaozheng decoction in addition to conventional basis. The traditional Chinese medical(TCM) symptom score, the curative effect of TCM, HPV viral loads and the changes of T lymphocyte subsets of the two groups before and after treatment were compared. The negative HPV conversion rate, clinical efficacy and the incidence of adverse reactions during treatment were compared.【Results】After treatment, the TCM symptom score, HPV viral load and Th17/Treg of the two groups were decreased (P<0.05), CD3⁺, CD4⁺ and CD4⁺/CD8⁺ were all increased (P<0.05). Compared with the control group, the TCM symptom score, HPV viral load and Th17/Treg of the observation group after treatment were all lower (P<0.05), and CD3⁺, CD4⁺ and CD4⁺/CD8⁺ were all higher (P<0.05). The total effective rate of TCM, HPV negative conversion rate and total clinical effective rate in the observation group were higher than those in the control group (P<0.05).The incidence of adverse reactions between the two groups during treatment was not different (P>0.05).【Conclusion】Modified Tiaomianxiaozheng decoction combined with conventional western medicine is used to treat HR-HPV persistent infection patients with spleen deficiency and dampness excess syndrome, which can significantly promote the remission of symptoms, reduce the load of HPV virus, regulate the immune function and improve the clinical efficacy. It has obvious curative effect and high safety.

Key words： Uterine Cervical Diseases/DT Papillomaviridae Drug Therapy, Combination Treatment Outcome

Received: 06 December 2021

PACS:

R711.74

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Xi-sheng
	HE Jing

Cite this article:

LI Xi-sheng,HE Jing. Clinical Efficacy of Modified TiaomianxiaozhengDecoction Combined with Conventional Western Medicinein the Treatment of Cervical High Risk HPV Persistent Infection[J]. JOURNAL OF CLINICAL RESEARCH, 2022, 39(3): 378-381.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2022.03.016 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2022/V39/I3/378

[1] 张思凯, 杨登峰, 李玲. 术前白蛋白水平对宫颈癌手术患者预后的影响[J].医学临床研究, 2021, 38(4):607-609.
[2] PAVER E C, CURRIE A M, GUPTA R, et al. Human papilloma virus related squamous cell carcinomas of the head and neck: diagnosis, clinical implications and detection of HPV [J].Pathology,2020, 52(2):179-191.
[3] 陈思含.干扰素凝胶结合口服中药治疗宫颈人乳头瘤病毒感染患者的有效性和安全性研究[J].中国妇幼保健, 2020, 35(10):23-26.
[4] 王文莹, 张敏, 杜敏. 宫颈人乳头瘤病毒(HPV)感染的中西医防治[J].中医药信息, 2020, 1(2):86-91.
[5] 蒋贵林, 安晓青, 余文婷, 等. 化湿解毒止带方治疗慢性宫颈炎伴HPV感染的临床疗效及对血清hs-CRP,TNF-α水平的影响[J].中华中医药学刊, 2020, 38(11):22-25.
[6] 国家中医药管理局. 中医病证诊断疗效标准[M]. 南京:南京大学出版社, 1994:102-108.
[7] 郑筱萸. 中药新药临床研究指导原则(试行)[M]. 北京:中国医药科技出版社, 2002: 20-25.
[8] 毛爽, 覃烨. 人类白细胞抗原E联合高危型人乳头瘤病毒检测在高级别鳞状上皮内病变和宫颈鳞癌中的诊断价值[J].医学临床研究, 2020, 37(10):1538-1541.
[9] 朱旭峰, 刘玉玲, 王俊玲. 汾阳地区1933例女性宫颈细胞样本HPV基因分型[J].中国微生态学杂志, 2019, 31(8):41-44.
[10] 马文擎,王世宣. 高危型HPV感染的防与治[J].实用妇产科杂志, 2020, 36(10):17-20.
[11] 陈茂鑫, 侯敏. 黄芪与红芪化学成分及药理作用研究进展与比较[J].中医药导报, 2019, 25(8):130-132.
[12] 高翠霞, 宋红湘, 杜丽华, 等. 益气健脾祛湿解毒法治疗生殖道HR-HPV感染[J].中医学报, 2019, 34(2):136-140.
[13] 周萍, 冉晓敏. 人乳头瘤病毒感染宫颈病变患者外周血辅助性T17细胞,调节性T细胞和炎症因子的变化及临床意义[J].中国妇幼保健, 2019, 34(6):1242-1245.